Wealth Trust Axiom LLC Abb Vie Inc. Transaction History

Wealth Trust Axiom LLC

$329 Million
Q3 2024

A detailed history of Wealth Trust Axiom LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Wealth Trust Axiom LLC holds 2,651 shares of ABBV stock, worth $464,375. This represents 0.16% of its overall portfolio holdings.

Number of Shares

2,651

Previous 2,536 4.53%

Holding current value

$464,375

Previous $434,000 20.51%

% of portfolio

0.16%

Previous 0.15%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$163.84 - $199.33 $18,841 - $22,922	115 Added 4.53%	2,651 $523,000
Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $11,454 - $13,376	-74 Reduced 2.84%	2,536 $434,000
Q1 2024 May 10, 2024	BUY	$159.82 - $182.1 $159 - $182	1 Added 0.04%	2,610 $475,000
Q4 2023 Feb 05, 2024	BUY	$137.6 - $154.97 $137 - $154	1 Added 0.04%	2,609 $404,000
Q3 2023 Nov 02, 2023	SELL	$133.59 - $154.65 $160,308 - $185,580	-1,200 Reduced 31.51%	2,608 $388,000
Q2 2023 Aug 04, 2023	BUY	$132.51 - $164.9 $132 - $164	1 Added 0.03%	3,808 $513,000
Q1 2023 May 02, 2023	BUY	$144.61 - $166.54 $144 - $166	1 Added 0.03%	3,807 $606,000
Q4 2022 Jan 30, 2023	BUY	$138.31 - $165.87 $20,746 - $24,880	150 Added 4.1%	3,806 $615,000
Q3 2022 Nov 02, 2022	BUY	$134.21 - $153.93 $134 - $153	1 Added 0.03%	3,656 $490,000
Q2 2022 Jul 27, 2022	BUY	$137.62 - $174.96 $13,762 - $17,496	100 Added 2.81%	3,655 $559,000
Q1 2022 May 09, 2022	BUY	$131.98 - $163.75 $131 - $163	1 Added 0.03%	3,555 $576,000
Q4 2021 Feb 02, 2022	BUY	$107.43 - $135.93 $35,451 - $44,856	330 Added 10.24%	3,554 $481,000
Q3 2021 Oct 14, 2021	SELL	$106.4 - $120.78 $1,064 - $1,207	-10 Reduced 0.31%	3,224 $347,000
Q2 2021 Jul 22, 2021	BUY	$105.21 - $117.21 $105 - $117	1 Added 0.03%	3,234 $364,000
Q3 2020 Oct 21, 2020	BUY	$85.91 - $100.83 $23,195 - $27,224	270 Added 9.11%	3,233 $283,000
Q1 2020 Apr 10, 2020	BUY	$64.5 - $97.79 $709 - $1,075	11 Added 0.37%	2,963 $225,000
Q4 2019 Feb 04, 2020	SELL	$72.13 - $90.25 $15,868 - $19,855	-220 Reduced 6.94%	2,952 $261,000
Q1 2019 May 03, 2019	SELL	$77.14 - $90.79 $3,317 - $3,903	-43 Reduced 1.34%	3,172 $255,000
Q4 2018 Feb 01, 2019	BUY	$77.85 - $96.01 $77 - $96	1 Added 0.03%	3,215 $296,000
Q3 2018 Nov 01, 2018	SELL	$88.91 - $98.84 $62,237 - $69,188	-700 Reduced 17.88%	3,214 $304,000
Q1 2018 May 01, 2018	SELL	$92.01 - $123.21 $15,181 - $20,329	-165 Reduced 4.05%	3,914 $370,000
Q4 2017 Feb 01, 2018	SELL	$89.56 - $98.21 $20,419 - $22,391	-228 Reduced 5.29%	4,079 $394,000
Q3 2017 Nov 01, 2017	BUY	$69.85 - $89.22 $300,843 - $384,270	4,307	4,307 $382,000

Others Institutions Holding ABBV

# of Institutions

3,855

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Trust Axiom LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Trust Axiom LLC with notifications on news.

Account

Wealth Trust Axiom LLC Abb Vie Inc. Transaction History